$NWBO
NORTHWEST BIOTHERAPEUTICS INC Stock $nwbo

$nwbo Overview Financials Valuation SEC Filings Company Website

2016 Q3 Form 10-Q Financial Statement

#000114420416133328 Filed on November 10, 2016

Income Statement

Concept	2016 Q3	2015 Q3	2014 Q4
Revenue	$159.0K	$291.0K	$872.0K
YoY Change	-45.36%	-50.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$4.580M	$4.330M	$5.240M
YoY Change	5.77%	4.59%	47.61%
% of Gross Profit
Research & Development	$21.09M	$9.138M	$21.40M
YoY Change	130.84%	-59.76%	92.45%
% of Gross Profit
Depreciation & Amortization	$55.00K	$29.00K	-$340.0K
YoY Change	89.66%	-91.62%
% of Gross Profit
Operating Expenses	$21.09M	$9.138M	$26.64M
YoY Change	130.84%	-59.76%	81.6%
Operating Profit	-$25.52M	-$13.21M
YoY Change	93.11%	-50.34%
Interest Expense	$691.0K	$1.046M	-$17.31M
YoY Change	-33.94%	285.98%	-1961.29%
% of Operating Profit
Other Income/Expense, Net	-$1.460M	$35.83M	-$17.26M
YoY Change	-104.08%	543.81%	447.9%
Pretax Income	-$29.23M	$22.62M	-$42.69M
YoY Change	-229.22%	-207.51%	152.75%
Income Tax
% Of Pretax Income
Net Earnings	-$29.23M	$22.62M	-$42.69M
YoY Change	-229.24%	-207.47%	152.72%
Net Earnings / Revenue	-18381.76%	7771.48%	-4895.07%
Basic Earnings Per Share	-$0.28	$0.29
Diluted Earnings Per Share	-$0.28	$0.25	-$642.1K
COMMON SHARES
Basic Shares Outstanding	114.8M shares	78.06M shares	62.22M shares
Diluted Shares Outstanding	114.8M shares	89.82M shares

Balance Sheet

Concept	2016 Q3	2015 Q3	2014 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$800.0K	$5.390M	$13.39M
YoY Change	-85.16%	285.0%	-27.62%
Cash & Equivalents	$1.487M	$5.392M	$13.39M
Short-Term Investments
Other Short-Term Assets	$1.480M	$1.700M	$1.260M
YoY Change	-12.94%	900.0%	740.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$2.270M	$7.090M	$14.64M
YoY Change	-67.98%	351.59%	-21.47%
LONG-TERM ASSETS
Property, Plant & Equipment	$46.55M	$43.97M	$40.00M
YoY Change	5.87%	83.87%	48091.57%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$120.0K	$590.0K	$55.00K
YoY Change	-79.66%	972.73%	0.0%
Total Long-Term Assets	$46.67M	$44.55M	$41.81M
YoY Change	4.76%	60.11%	30200.0%
TOTAL ASSETS
Total Short-Term Assets	$2.270M	$7.090M	$14.64M
Total Long-Term Assets	$46.67M	$44.55M	$41.81M
Total Assets	$48.94M	$51.64M	$56.46M
YoY Change	-5.23%	75.71%	200.55%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$25.18M	$22.79M	$9.826M
YoY Change	10.49%	98.17%	9.95%
Accrued Expenses	$1.300M	$1.070M	$1.211M
YoY Change	21.5%	35.44%	43.82%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$930.0K	$930.0K
YoY Change	-100.0%	0.0%	0.0%
Long-Term Debt Due	$21.09M	$240.0K	$6.370M
YoY Change	8687.5%	0.0%	2096.55%
Total Short-Term Liabilities	$53.96M	$87.25M	$75.01M
YoY Change	-38.15%	101.5%	280.96%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$21.60M	$16.38M
YoY Change	-100.0%	37.4%
Other Long-Term Liabilities		$140.0K	$98.00K
YoY Change		-91.25%
Total Long-Term Liabilities	$0.00	$21.74M	$16.48M
YoY Change	-100.0%	25.54%
TOTAL LIABILITIES
Total Short-Term Liabilities	$53.96M	$87.25M	$75.01M
Total Long-Term Liabilities	$0.00	$21.74M	$16.48M
Total Liabilities	$53.96M	$109.0M	$91.48M
YoY Change	-50.5%	79.83%	364.64%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock			$485.7M
YoY Change			29.43%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$5.020M	-$57.36M	-$35.03M
YoY Change
Total Liabilities & Shareholders Equity	$48.94M	$51.64M	$56.46M
YoY Change	-5.23%	75.68%	200.55%

Cashflow Statement

Concept	2016 Q3	2015 Q3	2014 Q4
OPERATING ACTIVITIES
Net Income	-$29.23M	$22.62M	-$42.69M
YoY Change	-229.24%	-207.47%	152.72%
Depreciation, Depletion And Amortization	$55.00K	$29.00K	-$340.0K
YoY Change	89.66%	-91.62%
Cash From Operating Activities	-$9.760M	$11.80M	-$18.60M
YoY Change	-182.71%	-239.15%	27.4%
INVESTING ACTIVITIES
Capital Expenditures	-$470.0K	-$1.990M	-$11.40M
YoY Change	-76.38%	-91.09%	-22900.0%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	$0.00
YoY Change		-100.0%	-100.0%
Cash From Investing Activities	-$470.0K	-$1.990M	-$11.39M
YoY Change	-76.38%	-90.77%	-350.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	7.680M	870.0K	41.98M
YoY Change	782.76%	-96.15%	63.41%
NET CHANGE
Cash From Operating Activities	-9.760M	$11.80M	-18.60M
Cash From Investing Activities	-470.0K	-1.990M	-11.39M
Cash From Financing Activities	7.680M	870.0K	41.98M
Net Change In Cash	-2.550M	$11.80M	11.99M
YoY Change	-121.61%	-258.18%	-23.34%
FREE CASH FLOW
Cash From Operating Activities	-$9.760M	$11.80M	-$18.60M
Capital Expenditures	-$470.0K	-$1.990M	-$11.40M
Free Cash Flow	-$9.290M	$13.79M	-$7.200M
YoY Change	-167.37%	-0.43%	-50.85%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2015Q3	us-gaap	Sales Revenue Net SalesRevenueNet	291000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	56562000	USD
	us-gaap	Revenue From Grants RevenueFromGrants	876000	USD
CY2015Q3	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	36490000	USD
	us-gaap	Interest Expense InterestExpense	3475000	USD
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	75774000	USD
CY2016Q3	nwbo	Development Stage Enterprise Deficit Accumulated During Development Stage1 DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage1	684770000	USD
CY2016Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1003000	USD
CY2015Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9138000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	19212000	USD
CY2015Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4366000	USD
CY2015Q3	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	13504000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-74898000	USD
CY2015Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-13213000	USD
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-12362000	USD
CY2015Q3	us-gaap	Interest Expense InterestExpense	1046000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-90663000	USD
CY2015Q3	us-gaap	Net Income Loss NetIncomeLoss	22615000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	72000	USD
CY2015Q3	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	384000	USD
CY2016Q3	us-gaap	Revenue From Grants RevenueFromGrants	159000	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	552000	USD
CY2016Q3	us-gaap	Sales Revenue Net SalesRevenueNet	159000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	43247000	USD
CY2016Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	21094000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	15323000	USD
CY2016Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4581000	USD
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	58570000	USD
CY2016Q3	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	25675000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-58018000	USD
CY2016Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-25516000	USD
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	17238000	USD
CY2016Q3	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-217000	USD
	us-gaap	Interest Expense InterestExpense	2138000	USD
	us-gaap	Revenue From Grants RevenueFromGrants	552000	USD
CY2016Q3	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-913000	USD
CY2016Q3	us-gaap	Interest Expense InterestExpense	691000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-49508000	USD
CY2016Q3	us-gaap	Net Income Loss NetIncomeLoss	-29227000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-4700000	USD
CY2016Q3	nwbo	Deemed Dividend Related To Warrant Modification DeemedDividendRelatedToWarrantModification	-3007000	USD
	nwbo	Deemed Dividend Related To Warrant Modification DeemedDividendRelatedToWarrantModification	-5647000	USD
CY2015Q3	nwbo	Deemed Dividend Related To Warrant Modification DeemedDividendRelatedToWarrantModification	0	USD
	nwbo	Deemed Dividend Related To Warrant Modification DeemedDividendRelatedToWarrantModification	0	USD
CY2016Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-32234000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-55154000	USD
CY2015Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	22615000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-90663000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	1126000	USD
	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	1077000	USD
	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	13700000	USD
	nwbo	Value Of Warrants Exercised For Cash ValueOfWarrantsExercisedForCash	8066000	USD
	nwbo	Adjustments To Additional Paid In Capital Modification On Warrant Exercise Price AdjustmentsToAdditionalPaidInCapitalModificationOnWarrantExercisePrice	5647000	USD
	us-gaap	Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings	5647000	USD
	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	98000	USD
	nwbo	Adjustments To Additional Paid In Capitaloffering Cost Related To Warrants Exercise AdjustmentsToAdditionalPaidInCapitalofferingCostRelatedToWarrantsExercise	795000	USD
	nwbo	Increase Decrease In Prepaid Expense And Other Current Assets IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets	-617000	USD
	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	1697000	USD
	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	6391000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-41555000	USD
	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	4770000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-4220000	USD
	nwbo	Stock And Warrants Issued To Related Party Expenses StockAndWarrantsIssuedToRelatedPartyExpenses	13654000	USD
	nwbo	Increase Decrease In Prepaid Expense And Other Current Assets IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets	563000	USD
	us-gaap	Proceeds From Sale Of Mortgage Loans Held For Sale ProceedsFromSaleOfMortgageLoansHeldForSale	0	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13390000	USD
CY2015Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5392000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	44000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	135000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1013000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	639000	USD
	nwbo	Deposits And Other Assets Noncurrent DepositsAndOtherAssetsNoncurrent	-70000	USD
	nwbo	Deposits And Other Assets Noncurrent DepositsAndOtherAssetsNoncurrent	42000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	20820000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	52577000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	3944000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-84000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-21011000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-7998000	USD
	us-gaap	Proceeds From Issuance Of Other Long Term Debt ProceedsFromIssuanceOfOtherLongTermDebt	550000	USD
	us-gaap	Proceeds From Issuance Of Other Long Term Debt ProceedsFromIssuanceOfOtherLongTermDebt	0	USD
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	1077000	USD
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	7431000	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	8066000	USD
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	0	USD
	nwbo	Proceeds From Issuance Of Capital Stock And Warrants ProceedsFromIssuanceOfCapitalStockAndWarrants	13700000	USD
	nwbo	Proceeds From Issuance Of Capital Stock And Warrants ProceedsFromIssuanceOfCapitalStockAndWarrants	0	USD
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	287000	USD
CY2016Q1	nwbo	Class Of Warrant Or Right Expired Weighted Average Exercise Price ClassOfWarrantOrRightExpiredWeightedAverageExercisePrice	11.86
CY2016Q2	nwbo	Weighted Average Exercise Price Exercised For Cash WeightedAverageExercisePriceExercisedForCash	0.96
	us-gaap	Share Based Compensation ShareBasedCompensation	98000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	3389000	USD
	nwbo	Payment Of Warrants Excercise Offering Cost PaymentOfWarrantsExcerciseOfferingCost	795000	USD
	nwbo	Payment Of Warrants Excercise Offering Cost PaymentOfWarrantsExcerciseOfferingCost	0	USD
CY2016Q3	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	9800000	USD
CY2016Q3	us-gaap	Accrued Environmental Loss Contingencies Noncurrent AccruedEnvironmentalLossContingenciesNoncurrent	6200000	USD
	us-gaap	Site Contingency Loss Exposure In Excess Of Accrual Best Estimate SiteContingencyLossExposureInExcessOfAccrualBestEstimate	6200000	USD
CY2016Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	351000	USD
CY2015Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	216000	USD
	us-gaap	Depreciation Depreciation	135000	USD
	us-gaap	Depreciation Depreciation	44000	USD
CY2016Q3	us-gaap	Depreciation Depreciation	55000	USD
CY2015Q3	us-gaap	Depreciation Depreciation	29000	USD
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	43601000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	28725000	shares
CY2016Q1	nwbo	Procees From Sale Of Availiable Securities Gross ProceesFromSaleOfAvailiableSecuritiesGross	10000000	USD
CY2016Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	9200000	USD
CY2016Q2	nwbo	Deemed Dividend Related To Warrant Modification DeemedDividendRelatedToWarrantModification	2600000	USD
CY2016Q2	nwbo	Class Of Warrant Or Right Expired ClassOfWarrantOrRightExpired	1614837	shares
CY2016Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	44444946	shares
CY2016Q2	nwbo	Class Of Warrant Or Right Outstanding Weighted Average Exercise Price ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice	2.67
CY2016Q2	nwbo	Class Of Warrant Or Right Granted In Registered Direct Offering ClassOfWarrantOrRightGrantedInRegisteredDirectOffering	2426440	shares
CY2016Q2	nwbo	Class Of Warrant Or Right Granted In Registerd Direct Offering Weighted Average Exercise Price ClassOfWarrantOrRightGrantedInRegisterdDirectOfferingWeightedAverageExercisePrice	1.02
CY2015Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	27267441	shares
CY2016Q1	nwbo	Class Of Warrant Or Right Expired ClassOfWarrantOrRightExpired	16791	shares
CY2016Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	42715146	shares
CY2015Q4	nwbo	Class Of Warrant Or Right Outstanding Weighted Average Exercise Price ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice	4.4
CY2016Q1	nwbo	Class Of Warrant Or Right Outstanding Weighted Average Exercise Price ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice	3.53
CY2016Q1	nwbo	Class Of Warrant Or Right Granted In Registered Direct Offering ClassOfWarrantOrRightGrantedInRegisteredDirectOffering	12058825	shares
CY2016Q1	nwbo	Class Of Warrant Or Right Granted In Registerd Direct Offering Weighted Average Exercise Price ClassOfWarrantOrRightGrantedInRegisterdDirectOfferingWeightedAverageExercisePrice	3.04
CY2016Q2	nwbo	Number Of Warrants Warrants Exercised For Cash NumberOfWarrantsWarrantsExercisedForCash	4411764	shares
CY2016Q2	nwbo	Class Of Warrant Or Right Expired Weighted Average Exercise Price ClassOfWarrantOrRightExpiredWeightedAverageExercisePrice	8.82
CY2016Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q3	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	0	USD
CY2015Q3	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	79000	USD
	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	0	USD
	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	0	USD
CY2016Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-32234000	USD
CY2015Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	22694000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-55154000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-90663000	USD
CY2016Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	114836000	shares
CY2015Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	78062000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	105501000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	74394000	shares
CY2016Q3	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
CY2015Q3	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	12373000	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
CY2016Q3	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
CY2015Q3	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	1811000	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
CY2016Q3	us-gaap	Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends	0	shares
CY2015Q3	us-gaap	Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends	2425000	shares
	us-gaap	Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends	0	shares
	us-gaap	Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends	0	shares
CY2016Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	114836000	shares
CY2015Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	89821000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	105501000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	74394000	shares
CY2016Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.28
CY2015Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.29
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.52
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.22
CY2016Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.28
CY2015Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.25
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.52
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.22
CY2016Q3	us-gaap	Secured Debt Current SecuredDebtCurrent	10148000	USD
CY2015Q4	us-gaap	Secured Debt Current SecuredDebtCurrent	11144000	USD
CY2016Q3	nwbo	Accrued Expenses Related Party AccruedExpensesRelatedParty	14000	USD
CY2015Q4	nwbo	Accrued Expenses Related Party AccruedExpensesRelatedParty	11000	USD
CY2016Q3	us-gaap	Interest Expense Other InterestExpenseOther	2000	USD
CY2015Q3	us-gaap	Interest Expense Other InterestExpenseOther	1000	USD
	us-gaap	Interest Expense Other InterestExpenseOther	2000	USD
	us-gaap	Interest Expense Other InterestExpenseOther	8000	USD
CY2016Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	691000	USD
CY2015Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	1046000	USD
	us-gaap	Interest Expense Debt InterestExpenseDebt	2138000	USD
	us-gaap	Interest Expense Debt InterestExpenseDebt	3475000	USD
CY2016Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	21570000	USD
CY2016Q3	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	483000	USD
CY2016Q3	us-gaap	Long Term Debt LongTermDebt	21087000	USD
CY2015Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	23731000	USD
CY2015Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	925000	USD
CY2015Q4	us-gaap	Long Term Debt LongTermDebt	22806000	USD
CY2016Q3	us-gaap	Notes Payable NotesPayable	135000	USD
CY2016Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2016Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	46901000	USD
CY2015Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	46373000	USD
CY2015Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
	us-gaap	Use Of Estimates UseOfEstimates	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><b><font style="FONT-SIZE: 10pt">Use of Estimates</font></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 44pt; MARGIN: 0in 0in 0pt; size: 8.5in 11.0in" align="justify"><i><font style="FONT-SIZE: 10pt">  </font></i></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; size: 8.5in 11.0in" align="justify"><font style="FONT-SIZE: 10pt">In preparing condensed consolidated financial statements in conformity with U.S. GAAP, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of expenses during the reporting period. Due to inherent uncertainty involved in making estimates, actual results reported in future periods may be affected by changes in these estimates. On an ongoing basis, the Company evaluates its estimates and assumptions. These estimates and assumptions include valuing equity securities in share-based payment arrangements, valuing environmental liabilities, estimating the fair value of equity instruments recorded as derivative liabilities, and estimating the useful lives of depreciable assets and whether impairment charges may apply.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2016Q3	nwbo	Convertible Notes Payable Related Parties Current ConvertibleNotesPayableRelatedPartiesCurrent	50000	USD
CY2015Q4	nwbo	Convertible Notes Payable Related Parties Current ConvertibleNotesPayableRelatedPartiesCurrent	50000	USD
CY2016Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2015Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2016Q3	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	2300000	USD
CY2016Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	40000000	shares
CY2015Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	40000000	shares
CY2016Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
	us-gaap	Induced Conversion Of Convertible Debt Expense InducedConversionOfConvertibleDebtExpense	1457000	USD
	us-gaap	Induced Conversion Of Convertible Debt Expense InducedConversionOfConvertibleDebtExpense	0	USD
CY2015Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2015Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2016Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2016Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	450000000	shares
CY2015Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	450000000	shares
CY2016Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	120776695	shares
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-433000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2016Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	120776695	shares
CY2015Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	95858087	shares
CY2015Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	95858087	shares
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	926000	USD
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	40000000	USD
CY2016Q3	us-gaap	Induced Conversion Of Convertible Debt Expense InducedConversionOfConvertibleDebtExpense	1457000	USD
CY2015Q3	us-gaap	Induced Conversion Of Convertible Debt Expense InducedConversionOfConvertibleDebtExpense	0	USD
	nwbo	Extinguishment Of Shares Payable ExtinguishmentOfSharesPayable	22539000	USD
	nwbo	Extinguishment Of Shares Payable ExtinguishmentOfSharesPayable	0	USD
	us-gaap	Stock Issued1 StockIssued1	28000	USD
	us-gaap	Stock Issued1 StockIssued1	0	USD
	nwbo	Issuance Of Common Stock For Conversion Of Accrued Interest IssuanceOfCommonStockForConversionOfAccruedInterest	387000	USD
	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	211000	USD
	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	0	USD
	nwbo	Accrued Exit Fee Incurred From Mortgage Loan AccruedExitFeeIncurredFromMortgageLoan	0	USD
	nwbo	Accrued Exit Fee Incurred From Mortgage Loan AccruedExitFeeIncurredFromMortgageLoan	51000	USD
	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	825000	USD
	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	264000	USD
	nwbo	Reclassification Of Warrant Liabilities Related To Cashless Warrants Exercise ReclassificationOfWarrantLiabilitiesRelatedToCashlessWarrantsExercise	0	USD
	nwbo	Reclassification Of Warrant Liabilities Related To Cashless Warrants Exercise ReclassificationOfWarrantLiabilitiesRelatedToCashlessWarrantsExercise	521000	USD
	nwbo	Redeemable Security Settlement RedeemableSecuritySettlement	0	USD
	nwbo	Redeemable Security Settlement RedeemableSecuritySettlement	299000	USD
CY2016Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-433000	USD
CY2015Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2016Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	-626000	USD
CY2015Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	461000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	-1126000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	-143000	USD
CY2016Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-28601000	USD
CY2015Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	22154000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-48382000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-90520000	USD
	nwbo	Stock And Warrants Issued During Period Value Private Placement Net Of Offering Costs StockAndWarrantsIssuedDuringPeriodValuePrivatePlacementNetOfOfferingCosts	926000	USD
	nwbo	Stock Issued During Period Value Conversion Of Accounts Payable To Common Stock StockIssuedDuringPeriodValueConversionOfAccountsPayableToCommonStock	28000	USD
	nwbo	Adjustments To Additional Paid In Capital Reclassification AdjustmentsToAdditionalPaidInCapitalReclassification	1872000	USD
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	0	USD
	nwbo	Adjustment To Additional Paidup Capital Extinguishment Of Shares Payable AdjustmentToAdditionalPaidupCapitalExtinguishmentOfSharesPayable	22539000	USD
	nwbo	Adjustment To Additional Paidup Capital Extinguishment Of Derivate Liability AdjustmentToAdditionalPaidupCapitalExtinguishmentOfDerivateLiability	10131000	USD
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	8885000	USD
CY2016Q3	nwbo	Number Of Warrants Granted To Cognate NumberOfWarrantsGrantedToCognate	4305772	shares
CY2016Q3	nwbo	Class Of Warrans Or Rights Warrants Issued ClassOfWarransOrRightsWarrantsIssued	6880574	shares
CY2016Q3	nwbo	Class Of Warrants Or Rights Warrants Exercised For Cash ClassOfWarrantsOrRightsWarrantsExercisedForCash	2555000	shares
CY2016Q3	nwbo	Class Of Warrants Or Rights Granted To Congnate Weighted Average Exercise Price ClassOfWarrantsOrRightsGrantedToCongnateWeightedAverageExercisePrice	4.27
CY2016Q3	nwbo	Class Of Warrant Or Right Increase Decrease Warrant Exercise Value ClassOfWarrantOrRightIncreaseDecreaseWarrantExerciseValue	3000000	USD
CY2016Q2	nwbo	Stock Outstanding Percentage Limit StockOutstandingPercentageLimit	0.2	pure
CY2016Q3	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	22500000	USD
CY2016Q3	nwbo	Class Of Warrant Or Rightwarrant Issue During Period ClassOfWarrantOrRightwarrantIssueDuringPeriod	1111111	shares
CY2016Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.45
CY2016Q3	nwbo	Class Of Warrant Or Rightwarrant Term ClassOfWarrantOrRightwarrantTerm	P5Y
CY2016Q3	nwbo	Number Of Warrant Granted To Investor NumberOfWarrantGrantedToInvestor	18428640	shares
CY2016Q3	nwbo	Class Of Warrants Or Rights Granted To Investors Weighted Average Exercise Price ClassOfWarrantsOrRightsGrantedToInvestorsWeightedAverageExercisePrice	0.64
CY2016Q3	nwbo	Class Of Warrant Or Right To Cognate Cancelled Weighted Average Exercise Price ClassOfWarrantOrRightToCognateCancelledWeightedAverageExercisePrice	0.35
CY2016Q3	nwbo	Class Of Warrant Or Rightnon Cognate Warrants Cancelled ClassOfWarrantOrRightnonCognateWarrantsCancelled	15806512	shares
CY2016Q3	nwbo	Class Of Warrant Or Right Expired ClassOfWarrantOrRightExpired	120979	shares
CY2016Q3	nwbo	Number Of Warrants Warrants Exercised For Cash NumberOfWarrantsWarrantsExercisedForCash	10945739	shares
CY2016Q3	nwbo	Weighted Average Exercise Price Exercised For Cash WeightedAverageExercisePriceExercisedForCash	0.35
CY2016Q3	nwbo	Class Of Warrant Or Right Expired Weighted Average Exercise Price ClassOfWarrantOrRightExpiredWeightedAverageExercisePrice	11.30
CY2016Q3	nwbo	Class Of Warrant Or Right Outstanding Weighted Average Exercise Price ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice	2.83
CY2016Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	40306128	shares
CY2016Q1	nwbo	Number Of Warrants Granted To Cognate NumberOfWarrantsGrantedToCognate	3405671	shares
CY2016Q2	nwbo	Number Of Warrants Granted To Cognate NumberOfWarrantsGrantedToCognate	5329961	shares
CY2016Q1	nwbo	Class Of Warrants Or Rights Granted To Congnate Weighted Average Exercise Price ClassOfWarrantsOrRightsGrantedToCongnateWeightedAverageExercisePrice	1.70
CY2016Q2	nwbo	Class Of Warrants Or Rights Granted To Congnate Weighted Average Exercise Price ClassOfWarrantsOrRightsGrantedToCongnateWeightedAverageExercisePrice	0.96
	nwbo	Stock And Warrants Issued During Period Value Conversion Of Debt And Accrued Interest StockAndWarrantsIssuedDuringPeriodValueConversionOfDebtAndAccruedInterest	1433000	USD
	nwbo	Extinguishment Of Derivative Liabilities ExtinguishmentOfDerivativeLiabilities	10131000	USD
	nwbo	Extinguishment Of Derivative Liabilities ExtinguishmentOfDerivativeLiabilities	0	USD
	nwbo	Return Of Common Stock And Warrants ReturnOfCommonStockAndWarrants	8000	USD
	nwbo	Return Of Common Stock And Warrants ReturnOfCommonStockAndWarrants	0	USD
CY2016Q3	nwbo	Class Of Warrans Or Rights Replacement Warrants Issued ClassOfWarransOrRightsReplacementWarrantsIssued	4305772	shares

Files In Submission

Name	View Source	Status
0001144204-16-133328-index-headers.html	Edgar Link	pending
0001144204-16-133328-index.html	Edgar Link	pending
0001144204-16-133328.txt	Edgar Link	pending
0001144204-16-133328-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
nwbo-20160930.xml	Edgar Link	completed
nwbo-20160930.xsd	Edgar Link	pending
nwbo-20160930_cal.xml	Edgar Link	unprocessable
nwbo-20160930_def.xml	Edgar Link	unprocessable
nwbo-20160930_lab.xml	Edgar Link	unprocessable
nwbo-20160930_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
v452478_10-q.htm	Edgar Link	pending
v452478_ex31-1.htm	Edgar Link	pending
v452478_ex32-1.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NWBO
NORTHWEST BIOTHERAPEUTICS INC Stock $nwbo

2016 Q3 Form 10-Q Financial Statement

#000114420416133328 Filed on November 10, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NWBO NORTHWEST BIOTHERAPEUTICS INC Stock $nwbo

2016 Q3 Form 10-Q Financial Statement

#000114420416133328 Filed on November 10, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NWBO
NORTHWEST BIOTHERAPEUTICS INC Stock $nwbo